Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Vesprini

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2003
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancerW L Alan Fung, Harvey Risch, John McLaughlin, et al.
The Canadian Journal of Urology|March 7, 2017
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approachAndrew Loblaw, Jack Barkin, Roger Buckley, et al.
Cancers|October 14, 2022
Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular StratificationEkaterina Olkhov-Mitsel, Yanhong Yu, Katherine Lajkosz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Long-term follow-up of a large active surveillance cohort of patients with prostate cancerLaurence Klotz, Danny Vesprini, Perakaa Sethukavalan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDanny Vesprini, Steven A Narod, John Trachtenberg, et al.
Clinical and Translational Radiation Oncology|January 18, 2024
Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancerWee Loon Ong, M Allan Hupman, Melanie Davidson, et al.
Journal of Clinical Pathology|May 31, 2020
Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString studyEkaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K Liu, et al.
Clinical Breast Cancer|July 8, 2018
A Systematic Review of Heart Dose in Breast RadiotherapyLeah Drost, Caitlin Yee, Henry Lam, et al.
Clinical Genitourinary Cancer|March 9, 2024
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer CentreXin Wang, Larissa Waldman, Yael Silberman, et al.
Clinical Breast Cancer|August 4, 2018
Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized TrialsCaitlin Yee, Katie Wang, Rashi Asthana, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2003
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancerW L Alan Fung, Harvey Risch, John McLaughlin, et al.
The Canadian Journal of Urology|March 7, 2017
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approachAndrew Loblaw, Jack Barkin, Roger Buckley, et al.
Cancers|October 14, 2022
Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular StratificationEkaterina Olkhov-Mitsel, Yanhong Yu, Katherine Lajkosz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Long-term follow-up of a large active surveillance cohort of patients with prostate cancerLaurence Klotz, Danny Vesprini, Perakaa Sethukavalan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDanny Vesprini, Steven A Narod, John Trachtenberg, et al.
Clinical and Translational Radiation Oncology|January 18, 2024
Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancerWee Loon Ong, M Allan Hupman, Melanie Davidson, et al.
Journal of Clinical Pathology|May 31, 2020
Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString studyEkaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K Liu, et al.
Clinical Breast Cancer|July 8, 2018
A Systematic Review of Heart Dose in Breast RadiotherapyLeah Drost, Caitlin Yee, Henry Lam, et al.
Clinical Genitourinary Cancer|March 9, 2024
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer CentreXin Wang, Larissa Waldman, Yael Silberman, et al.
Clinical Breast Cancer|August 4, 2018
Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized TrialsCaitlin Yee, Katie Wang, Rashi Asthana, et al.
Pageof 15